BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/15/2019 10:30:02 AM | Browse: 880 | Download: 1196
 |
Received |
|
2019-02-23 06:13 |
|
Peer-Review Started |
|
2019-02-24 01:42 |
|
To Make the First Decision |
|
2019-04-16 06:47 |
|
Return for Revision |
|
2019-04-19 06:47 |
|
Revised |
|
2019-04-25 15:13 |
|
Second Decision |
|
2019-06-10 07:34 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2019-06-13 02:20 |
|
Articles in Press |
|
2019-06-13 02:20 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2019-07-15 07:56 |
|
Publish the Manuscript Online |
|
2019-07-15 10:30 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Minireviews |
| Article Title |
Utilizing gastric cancer organoids to assess tumor biology and personalize medicine
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Miranda Lin, Mei Gao, Michael J Cavnar and Joseph Kim |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Joseph Kim, FACS, MD, Chief Doctor, Surgical Oncologist, Department of Surgery, University of Kentucky, 800 Rose St., Lexington, KY 40536, United States. joseph.kim@uky.edu |
| Key Words |
Organoids; Gastric cancer; Cancer models; Drug sensitivity; Drug screening; Personalized medicine |
| Core Tip |
Patient-derived organoids are three-dimensional models of human cancer useful for investigating tumor biology and drug discovery. There are now many reports on the utility of organoids in cancer research and personalized therapy. However, none focus on the use of organoid technology in improving outcomes for patients with gastric cancer (GC), which is one of the deadliest cancers worldwide. Our objective is to report the current progress in GC organoid technology in comparison to traditional cancer models and evaluate their potential role in informing personalized clinical decision making for patients with GC. |
| Publish Date |
2019-07-15 10:30 |
| Citation |
Lin M, Gao M, Cavnar MJ, Kim J. Utilizing gastric cancer organoids to assess tumor biology and personalize medicine. World J Gastrointest Oncol 2019; 11(7): 509-517 |
| URL |
https://www.wjgnet.com/1948-5204/full/v11/i7/509.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v11.i7.509 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
